Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Cerecor’s Phase II clinical trial of CERC-301 to treat MDD fails to meet primary endpoint

Go Top